Apomorphine-induced eosinophilic panniculitis and hypereosinophilia in Parkinson disease

Neurology. 2005 Jan 25;64(2):392-3. doi: 10.1212/01.WNL.0000149757.47854.6F.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antiparkinson Agents / adverse effects*
  • Antiparkinson Agents / therapeutic use
  • Apomorphine / adverse effects*
  • Apomorphine / therapeutic use
  • Dopamine Agonists / adverse effects*
  • Dopamine Agonists / therapeutic use
  • Drug Eruptions / etiology*
  • Female
  • Humans
  • Hypereosinophilic Syndrome / chemically induced*
  • Middle Aged
  • Panniculitis / chemically induced*
  • Parkinson Disease / complications*
  • Parkinson Disease / drug therapy

Substances

  • Antiparkinson Agents
  • Dopamine Agonists
  • Apomorphine